TY - JOUR T1 - Community responses during early phase of the COVID-19 epidemic: a cross-sectional study JF - medRxiv DO - 10.1101/2020.04.04.20053546 SP - 2020.04.04.20053546 AU - Mohammad Hossein Delshad AU - Fatemeh Pourhaji AU - Fahimeh Pourhaji AU - Saeed Reza Ghanbarizadeh AU - Hassan Azhdari Zarmehri AU - Edris Bazrafshan AU - Mahdi Gholian-Aval Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/07/2020.04.04.20053546.abstract N2 - Community responses are important for outbreak management during the early phase when preventive interventions are the major options. Therefore, this study aims to examine the behavioral responses of the community during the early phase of the COVID-19 epidemic in the Razavi Khorasan Province of Iran. A cross-sectional online survey was proceeded after confirmed COVID-19 in Iran. The population of the study was 500 residents of Razavi Khorasan areas were randomly surveyed. The research tool was demographic and risk perception questionnaire and Anxiety was assessed using the 7-item GAD Scale. The data analyzed using the SPSS statistical version (V.20). The means of age participants was 31.9±11.9. The mean GAD-7 scores were 6.4±5.2 and 92.4% had moderate or severe anxiety (GAD-7 score ≥10). Many respondents reported their health status were very good or good (62.2 %; 311/500). About a quarter of them had respiratory symptoms in the past 14 days and experienced 20% of them travelled outside the Razavi Khorasan Province in the previous. Risk perception toward COVID-19 in the community of the Razavi Khorasan Province was moderate. Most participants are alert to disease progression. This study suggested timely behavioral assessment of the community is beneficial and effective to inform next intervention, and risk communication strategies in epidemic disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank all the individuals who took part in the study. The authors also thank Torbat Heydariyeh University of Medical Sciences for its financial support for this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesI share all the data in my article from manuscripts http://delshad264.blogfa.com/ ER -